These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient. Roncella S, Di Celle PF, Cutrona G, Carbone A, Sessarego M, Landonio G, Foà R, Rowe M, Ferrarini M. Leuk Lymphoma; 1993 Jan; 9(1-2):157-64. PubMed ID: 8386576 [Abstract] [Full Text] [Related]
5. Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma. Zunino A, Viaggi S, Ottaggio L, Fronza G, Schenone A, Roncella S, Abbondandolo A. Haematologica; 2000 Mar; 85(3):250-5. PubMed ID: 10702812 [Abstract] [Full Text] [Related]
6. A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. Jain R, Roncella S, Hashimoto S, Carbone A, Francia di Celle P, Foa R, Ferrarini M, Chiorazzi N. J Immunol; 1994 Jul 01; 153(1):45-52. PubMed ID: 8207254 [Abstract] [Full Text] [Related]
7. Functional analysis of the p53 protein in AIDS-related non-Hodgkin's lymphomas and polymorphic lymphoproliferations. Martin A, Flaman JM, Frebourg T, Davi F, El Mansouri S, Amouroux J, Raphaël M. Br J Haematol; 1998 May 01; 101(2):311-7. PubMed ID: 9609527 [Abstract] [Full Text] [Related]
9. Topological organization of the MYC/IGK locus in Burkitt's lymphoma cells assessed by nuclear halo preparations. Rätsch A, Joos S, Kioschis P, Lichter P. Exp Cell Res; 2002 Feb 01; 273(1):12-20. PubMed ID: 11795942 [Abstract] [Full Text] [Related]
11. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences. Sandlund JT, Neckers LM, Schneller HE, Woodruff LS, Magrath IT. Cancer Res; 1993 Jan 01; 53(1):127-32. PubMed ID: 8416737 [Abstract] [Full Text] [Related]
13. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53. Ramqvist T, Magnusson KP, Wang Y, Szekely L, Klein G, Wiman KG. Oncogene; 1993 Jun 01; 8(6):1495-500. PubMed ID: 8502475 [Abstract] [Full Text] [Related]
14. [Molecular genetic features of sporadic Burkitt's lymphoma in children]. Yang WP, Huang H, Gong LP, Wu Y, Xu HY, Zou Y, Lü BB, Zhong HS, Deng QQ, Xiao Q, Zeng ST, Zhu CD. Zhonghua Bing Li Xue Za Zhi; 2010 Dec 01; 39(12):819-24. PubMed ID: 21215097 [Abstract] [Full Text] [Related]
15. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases. Preudhomme C, Dervite I, Wattel E, Vanrumbeke M, Flactif M, Lai JL, Hecquet B, Coppin MC, Nelken B, Gosselin B. J Clin Oncol; 1995 Apr 01; 13(4):812-20. PubMed ID: 7707106 [Abstract] [Full Text] [Related]
16. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene. Fiancette R, Rouaud P, Vincent-Fabert C, Laffleur B, Magnone V, Cogné M, Denizot Y. J Immunol; 2011 Dec 01; 187(11):5772-82. PubMed ID: 22039300 [Abstract] [Full Text] [Related]
17. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW. Nature; 2005 Aug 11; 436(7052):807-11. PubMed ID: 16094360 [Abstract] [Full Text] [Related]
18. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes. Rapoport AP, Simons-Evelyn M, Chen T, Sidell R, Luhowskyj S, Rosell K, Obrig T, Hicks D, Hinkle PM, Nahm M, Insel RA, Abboud CN. Blood Cells Mol Dis; 2001 Aug 11; 27(3):610-24. PubMed ID: 11482875 [Abstract] [Full Text] [Related]
19. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. Clark HM, Yano T, Otsuki T, Jaffe ES, Shibata D, Raffeld M. Cancer Res; 1994 Jul 01; 54(13):3383-6. PubMed ID: 8012955 [Abstract] [Full Text] [Related]
20. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Madisen L, Groudine M. Genes Dev; 1994 Sep 15; 8(18):2212-26. PubMed ID: 7958890 [Abstract] [Full Text] [Related] Page: [Next] [New Search]